Literature DB >> 33318627

Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment.

Alejandra Gomez-Cadena1, Laurie Spehner2, Marie Kroemer2,3, Myriam Ben Khelil2, Kevin Bouiller4,5, Grégory Verdeil6, Sara Trabanelli1, Christophe Borg2,7, Romain Loyon2, Camilla Jandus8.   

Abstract

Entities:  

Year:  2020        PMID： 33318627     DOI： 10.1038/s41423-020-00596-2

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  13 in total

1.  The Karolinska KI/K COVID-19 Immune Atlas: An open resource for immunological research and educational purposes.

Authors:  Hans-Gustaf Ljunggren; Eivind Heggernes Ask; Martin Cornillet; Benedikt Strunz; Puran Chen; Jagadeeswara Rao Muvva; Mira Akber; Marcus Buggert; Benedict J Chambers; Angelica Cuapio; Majda Dzidic; Iva Filipovic; Malin Flodström-Tullberg; Marina Garcia; Jean-Baptiste Gorin; Sara Gredmark-Russ; Laura Hertwig; Jonas Klingström; Efthymia Kokkinou; Egle Kvedaraite; Magda Lourda; Jenny Mjösberg; Christopher Maucourant; Anna Norrby-Teglund; Laura M Palma Medina; Tiphaine Parrot; André Perez-Potti; Andrea Ponzetta; Emma Ringqvist; Olga Rivera-Ballesteros; Olav Rooyackers; Johan K Sandberg; J Tyler Sandberg; Takuya Sekine; Mattias Svensson; Renata Varnaite; David Wullimann; Lars I Eriksson; Soo Aleman; Karl-Johan Malmberg; Kristoffer Strålin; Niklas K Björkström
Journal:  Scand J Immunol       Date:  2022-06-02       Impact factor: 3.889

2.  Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity.

Authors:  Eric Alves; Emily McLeish; Pilar Blancafort; Jerome D Coudert; Silvana Gaudieri
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

Review 3.  Features of HLA class I expression and its clinical relevance in SARS-CoV-2: What do we know so far?

Authors:  Abdellatif Bouayad
Journal:  Rev Med Virol       Date:  2021-04-01       Impact factor: 11.043

Review 4.  The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.

Authors:  Ren-Jun Hsu; Wei-Chieh Yu; Guan-Ru Peng; Chih-Hung Ye; SuiYun Hu; Patrick Chun Theng Chong; Kah Yi Yap; Jamie Yu Chieh Lee; Wei-Chen Lin; Shu-Han Yu
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

Review 5.  Role of ILC2 in Viral-Induced Lung Pathogenesis.

Authors:  Wendy Fonseca; Nicholas W Lukacs; Srikanth Elesela; Carrie-Anne Malinczak
Journal:  Front Immunol       Date:  2021-04-19       Impact factor: 7.561

6.  SARS-CoV2 pneumonia recovery is linked to expansion of innate lymphoid cells type 2 expressing CCR10.

Authors:  André M C Gomes; Guilherme B Farias; Manuel Dias-Silva; Joel Laia; Amelia C Trombetta; Ana Godinho-Santos; Pedro Rosmaninho; Diana F Santos; Carolina M Conceição; Renato Costa-Reis; Maria Adão-Serrano; Catarina Mota; Afonso R M Almeida; Ana E Sousa; Susana M Fernandes
Journal:  Eur J Immunol       Date:  2021-10-20       Impact factor: 6.688

Review 7.  Comprehensive Analysis of the ILCs and Unconventional T Cells in Virus Infection: Profiling and Dynamics Associated with COVID-19 Disease for a Future Monitoring System and Therapeutic Opportunities.

Authors:  Elena Lo Presti; Andrea De Gaetano; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Cells       Date:  2022-02-04       Impact factor: 6.600

Review 8.  Heterogeneity of type 2 innate lymphoid cells.

Authors:  Hergen Spits; Jenny Mjösberg
Journal:  Nat Rev Immunol       Date:  2022-03-30       Impact factor: 53.106

Review 9.  The deciphering of the immune cells and marker signature in COVID-19 pathogenesis: An update.

Authors:  Saade Abdalkareem Jasim; Roaa Salih Mahdi; Dmitry Olegovich Bokov; Mazin A A Najm; Guzal N Sobirova; Zarnigor O Bafoyeva; Ahmed Taifi; Ola Kamal A Alkadir; Yasser Fakri Mustafa; Rasoul Mirzaei; Sajad Karampoor
Journal:  J Med Virol       Date:  2022-07-23       Impact factor: 20.693

Review 10.  Functional Contribution and Targeted Migration of Group-2 Innate Lymphoid Cells in Inflammatory Lung Diseases: Being at the Right Place at the Right Time.

Authors:  Stefan Wirtz; Anja Schulz-Kuhnt; Markus F Neurath; Imke Atreya
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.